Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Aim. To study the role of CT perfusion in the differential diagnosis of histological subtypes of supratentorial malignant gliomas and to determine the degree of their malignancy. Materials and methods. The study included 34 patients (20 men and 14 women, with an average age of 52 years) with newly detected supratenorial glial tumors, who subsequently underwent neurosurgical treatment in the NMIC of neurosurgery with histological verification of the diagnosis. Depending on the histological diagnosis, three groups of patients were identified: 1) anaplastic astrocytomas, 2) glioblastomas, 3) anaplastic oligodendrogliomas. The CT-perfusion protocol was performed on a 64-slice Optima 660 (GE) scanner and consisted of three separate parts: a low-dose axial CT of the brain with a slice thickness of 5 mm (90 kV), a perfusion protocol performed according to a prolonged scheme, with two consecutive continuous series of scans, and a post-contrast series of CT images in a spiral scanning mode. In addition, all patients underwent an MRI examination (using a Signa Hdxt 3.0 T (GE) MR scanner, in T2, T2-FLAIR, SWAN, DWI, and T1 modes before and after contrast enhancement).Results. The study demonstrated that anaplastic astrocytomas are characterized by significantly low absolute and normalized hemodynamics parameters (BF, BV, PS) when compared with glioblastomas, and significantly low absolute maximum values of blood flow (BF) and blood volume (BV) when compared with the group of anaplastic oligodendrogliomas. CT perfusion using the normalized permeability index (PS) can reliably differentiate glioblastomas and anaplastic oligodendrogliomas. Perfusion parameters, both absolute and normalized, did not show statistically significant differences in the differential diagnosis of various molecular and genetic subtypes of anaplastic astrocytomas.Conclusion. CT perfusion using all hemodynamic parameters demonstrated high reliability and efficacy in distinguishing between glioblastomas and anaplastic astrocytomas. Further research is required to evaluate the effectiveness of the method in distinguishing glioblastomas from anaplastic oligodendrogliomas.
Aim. To study the role of CT perfusion in the differential diagnosis of histological subtypes of supratentorial malignant gliomas and to determine the degree of their malignancy. Materials and methods. The study included 34 patients (20 men and 14 women, with an average age of 52 years) with newly detected supratenorial glial tumors, who subsequently underwent neurosurgical treatment in the NMIC of neurosurgery with histological verification of the diagnosis. Depending on the histological diagnosis, three groups of patients were identified: 1) anaplastic astrocytomas, 2) glioblastomas, 3) anaplastic oligodendrogliomas. The CT-perfusion protocol was performed on a 64-slice Optima 660 (GE) scanner and consisted of three separate parts: a low-dose axial CT of the brain with a slice thickness of 5 mm (90 kV), a perfusion protocol performed according to a prolonged scheme, with two consecutive continuous series of scans, and a post-contrast series of CT images in a spiral scanning mode. In addition, all patients underwent an MRI examination (using a Signa Hdxt 3.0 T (GE) MR scanner, in T2, T2-FLAIR, SWAN, DWI, and T1 modes before and after contrast enhancement).Results. The study demonstrated that anaplastic astrocytomas are characterized by significantly low absolute and normalized hemodynamics parameters (BF, BV, PS) when compared with glioblastomas, and significantly low absolute maximum values of blood flow (BF) and blood volume (BV) when compared with the group of anaplastic oligodendrogliomas. CT perfusion using the normalized permeability index (PS) can reliably differentiate glioblastomas and anaplastic oligodendrogliomas. Perfusion parameters, both absolute and normalized, did not show statistically significant differences in the differential diagnosis of various molecular and genetic subtypes of anaplastic astrocytomas.Conclusion. CT perfusion using all hemodynamic parameters demonstrated high reliability and efficacy in distinguishing between glioblastomas and anaplastic astrocytomas. Further research is required to evaluate the effectiveness of the method in distinguishing glioblastomas from anaplastic oligodendrogliomas.
Overall survival and recurrence-free survival (RFS) in patients with glioblastoma directly depend on the radicality of tumor resection. According to a number of literature sources, it is known that endoscopic surgeries under fluorescence control increase the rate of total resection. However, until now, there is little data on whether endoscopic resection with fluorescence control affects RFS and overall survival of patients with glioblastoma. The aim of our study was to investigate the effect of intraoperative endoscopic and fluorescence control on overall survival and RFS in patients with glioblastoma. A retrospective single-center analysis was performed in 20 patients with glioblastoma. Ten patients underwent tumor resection using an operating microscope with endoscopic and fluorescence control. In 5 patients, 5-aminolevulinic acid (5-ALA) (alasens) at a dose of 20 mg/ kg was used as a photosensitizer, in 5 patients, chlorin e6 (photoditazine) at a dose of 1 mg/kg. Ten patients underwent resection under endoscopic control, but without fluorescence control. Both cohorts of patients were comparable in age, functional status, tumor localization, adjuvant treatment methods, and molecular status. The criteria for assessing the effectiveness of the study in the groups were: the radicality of the surgical intervention according to postoperative magnetic resonance imaging with contrast enhancement, as well as the median RFS and OS in patients. In the group of combined surgery under microscopic and fluorescence control with an endoscope, the rate of total tumor resection was higher than in the group of patients who underwent only surgery under a microscope and an endoscope without fluorescence control (100% versus 60%; p = 0.002). Median OS (20.2 months (95% CI 11.9-28.6) versus 16.3 months (95% CI 11.0-20.9); (p = 0.003)) and median RFS (11.7 months (95% CI 9.8-15.7) versus 9.8 months (95% CI 6.1-13.4) (p = 0.04)), were also statistically significantly higher compared to the group of patients who received treatment to the same extent, but without fluorescence control. As our experience has shown, the use of fluorescence control during tumor resection in patients with glioblastoma with endoscopic assistance is certainly necessary, given the technical capabilities available, as it has a positive effect on the treatment results for this category of patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.